The brain constitutes a privileged transplantation site. Under appropriate conditions neuronal tissues can survive transplantation into the damaged brain, integrate with the host, and alleviate functional impairments associated with neurological disease.The experimental techniques have been developed to the point of clinical application with demonstrable benefit in Parkinson's disease, and similar applications in Huntington's disease appear to be imminent. Nevertheless, present techniques require use of embryonic/fetal tissues which will limit the availability of donors for the foreseeable future.There is an active search for alternative sources of tissue that are equally effective but more readily available, including engineered ...
The clinical use of cell transplantation for Parkinson's disease has been built on a strong fou...
Restoration of the damaged central nervous system is a vast challenge. However, there is a great nee...
The transplantation of human fetal ventral mesencephalic (VM) tissue for patients with advanced Park...
Parkinson's and Huntington's diseases are progressive neurodegenerative disorders of the central ner...
The use of transplantation (TR) of fetal neural tissue as a therapeutic method started much later in...
The gene for Huntington’s disease was identified in 1993 as being a CAG repeat expansion in exon 1 o...
Neurodegenerative disorders such as Parkinson’s diseases (PD) and Huntington’s diseases (HD), neuron...
Transplants of cells and tissues to the central nervous system of adult mammals can, under appropria...
During the last 30 years, the promise of neural transplantation as a therapeutic strategy for neurod...
Studies in experimental animals have demonstrated the efficacy of transplanting fetal neural tissues...
Damage to the central nervous system was once considered irreparable. However, there is now growing ...
Huntington’s disease is a dominantly inherited neurodegenerative disorder, usually starting in mid-l...
It has long been considered that central nervous system would not regenerate after injury, but this ...
Over the past decade, neural grafting has emerged as a new treatment option for Parkinson's disease....
In Cell Transplantation for Neurological Disorders, distinguished medical researchers from around th...
The clinical use of cell transplantation for Parkinson's disease has been built on a strong fou...
Restoration of the damaged central nervous system is a vast challenge. However, there is a great nee...
The transplantation of human fetal ventral mesencephalic (VM) tissue for patients with advanced Park...
Parkinson's and Huntington's diseases are progressive neurodegenerative disorders of the central ner...
The use of transplantation (TR) of fetal neural tissue as a therapeutic method started much later in...
The gene for Huntington’s disease was identified in 1993 as being a CAG repeat expansion in exon 1 o...
Neurodegenerative disorders such as Parkinson’s diseases (PD) and Huntington’s diseases (HD), neuron...
Transplants of cells and tissues to the central nervous system of adult mammals can, under appropria...
During the last 30 years, the promise of neural transplantation as a therapeutic strategy for neurod...
Studies in experimental animals have demonstrated the efficacy of transplanting fetal neural tissues...
Damage to the central nervous system was once considered irreparable. However, there is now growing ...
Huntington’s disease is a dominantly inherited neurodegenerative disorder, usually starting in mid-l...
It has long been considered that central nervous system would not regenerate after injury, but this ...
Over the past decade, neural grafting has emerged as a new treatment option for Parkinson's disease....
In Cell Transplantation for Neurological Disorders, distinguished medical researchers from around th...
The clinical use of cell transplantation for Parkinson's disease has been built on a strong fou...
Restoration of the damaged central nervous system is a vast challenge. However, there is a great nee...
The transplantation of human fetal ventral mesencephalic (VM) tissue for patients with advanced Park...